Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Moiola

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Human Brain Mapping|February 11, 2014
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosisMaria A Rocca, Paola Valsasina, Martina Absinta, et al.
Rheumatology (Oxford, England)|December 28, 2020
Quantitative MRI adds to neuropsychiatric lupus diagnosticsGiuseppe A Ramirez, Maria A Rocca, Paolo Preziosa, et al.
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2025
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosisAntonino Giordano, Arianna Giliberti, Ferdinando Clarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titresGloria Dalla Costa, Letizia Leocani, Marco Pisa, et al.
Annals of Neurology|February 15, 2019
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patientsGloria Dalla Costa, Vittorio Martinelli, Lucia Moiola, et al.
Journal of Autoimmunity|May 26, 2023
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunityEmanuela Colombo, Marco Di Dario, Ramesh Menon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 19, 2023
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year studyFederico Montini, Agostino Nozzolillo, Nicolò Tedone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2025
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSDLaura Cacciaguerra, Loredana Storelli, Elisabetta Pagani, et al.
Journal of Neurology|June 28, 2025
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world studyTiziana Zaccone, Lucia Moiola, Simone Guerrieri, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Human Brain Mapping|February 11, 2014
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosisMaria A Rocca, Paola Valsasina, Martina Absinta, et al.
Rheumatology (Oxford, England)|December 28, 2020
Quantitative MRI adds to neuropsychiatric lupus diagnosticsGiuseppe A Ramirez, Maria A Rocca, Paolo Preziosa, et al.
European Journal of Neurology|May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experienceSimone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2025
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosisAntonino Giordano, Arianna Giliberti, Ferdinando Clarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titresGloria Dalla Costa, Letizia Leocani, Marco Pisa, et al.
Annals of Neurology|February 15, 2019
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patientsGloria Dalla Costa, Vittorio Martinelli, Lucia Moiola, et al.
Journal of Autoimmunity|May 26, 2023
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunityEmanuela Colombo, Marco Di Dario, Ramesh Menon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 19, 2023
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year studyFederico Montini, Agostino Nozzolillo, Nicolò Tedone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2025
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSDLaura Cacciaguerra, Loredana Storelli, Elisabetta Pagani, et al.
Journal of Neurology|June 28, 2025
Long-term effectiveness and safety of ocrelizumab: a single-centre real-world studyTiziana Zaccone, Lucia Moiola, Simone Guerrieri, et al.
Pageof 16